Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2

被引:184
作者
Vajkoczy, P
Farhadi, M
Gaumann, A
Heidenreich, R
Erber, R
Wunder, A
Tonn, JC
Menger, MD
Breier, G
机构
[1] Univ Heidelberg, Klinikum Mannheim, Dept Neurosurg, D-68167 Mannheim, Germany
[2] Max Planck Inst Physiol & Clin Res, Dept Mol Biol, Bad Nauhem, Germany
[3] German Canc Res Ctr, Dept Radiochem & Radiopharmacol, D-6900 Heidelberg, Germany
[4] Univ Munich, Klinikum Grosshadern, Dept Neurosurg, D-8000 Munich, Germany
[5] Univ Saarland, Inst Clin & Expt Surg, D-6650 Homburg, Germany
关键词
D O I
10.1172/JCI200214105
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumors have been thought to initiate as avascular aggregates of malignant cells that only later induce vascularization. Recently, this classic concept of tumor angiogenesis has been challenged by the suggestion that tumor cells grow by co-opting preexisting host vessels and thus initiate as well-vascularized tumors without triggering angiogenesis. To discriminate between these two mechanisms, we have used intravital epifluorescence microscopy and multi-photon laser scanning confocal microscopy to visualize C6 microglioma vascularization and tumor cell behavior. To address the mechanisms underlying tumor initiation, we assessed the expression of VEGF, VEGF receptor-2 (VEGFR-2), and angiopoietin-2 (Ang-2), as well as endothelial cell proliferation. We show that multicellular aggregates (much less than 1 mm(3)) initiate vascular growth by angiogenic sprouting via the simultaneous expression of VEGFR-2 and Ang-2 by host and tumor endothelium. Host blood vessels are not co-opted by tumor cells but rather are used as trails for tumor cell invasion of the host tissue. Our data further suggest that the established microvasculature of growing tumors is characterized by a continuous vascular remodelin, putatively mediated by the expression of VEGF and Ang-2. The results of this stud), suggest a new concept of vascular tumor initiation that may have important implications for the clinical application of antiangiogenic strategies.
引用
收藏
页码:777 / 785
页数:9
相关论文
共 43 条
[1]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[2]   C6 GLIOMA CELL INVASION AND MIGRATION OF RAT-BRAIN AFTER NEURAL HOMOGRAFTING - ULTRASTRUCTURE [J].
BERNSTEIN, JJ ;
GOLDBERG, WJ ;
LAWS, ER ;
CONGER, D ;
MORREALE, V ;
WOOD, LR .
NEUROSURGERY, 1990, 26 (04) :622-628
[3]  
BREIER G, 1992, DEVELOPMENT, V114, P521
[4]  
Breier G, 1999, METH MOL B, V96, P107
[5]  
Brown LF, 1996, AM J PATHOL, V148, P1065
[6]  
Etoh T, 2001, CANCER RES, V61, P2145
[7]   Molecular and biological properties of vascular endothelial growth factor [J].
Ferrara, N .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (07) :527-543
[8]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[9]  
GIESE A, 1994, CANCER RES, V54, P3897
[10]   TUMOR DORMANCY IN-VIVO BY PREVENTION OF NEOVASCULARIZATION [J].
GIMBRONE, MA ;
COTRAN, RS ;
FOLKMAN, J ;
LEAPMAN, SB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (02) :261-&